Skip to main content
Equibles

MARSHALL WACE, LLP

Position in MYGN — Myriad Genetics Inc

CIK 1318757 LONDON, X0
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,982,210
+$2,015,299 QoQ
Shares Held
1,222,804
+10.8% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 196 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $832,085,876 across 26 Diagnostics & Research names. MYGN ranks #15 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 WAT
Waters Corp /De/
 581,332 $218,022,752
2 QGEN
Qiagen N.V.
 3,491,480 $136,516,866
3 MTD
Mettler Toledo International Inc/
 76,977 $98,338,886
4 CRL
Charles River Laboratories International, Inc.
 342,995 $77,787,835
5 DGX
Quest Diagnostics Inc
 269,760 $57,175,631
6 IDXX
Idexx Laboratories Inc /De
 93,128 $49,026,303
7 NTRA
Natera, Inc.
 131,663 $35,739,920
8 ICLR
Icon PLC
 175,440 $30,475,681

All Filings in MYGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,982,210 1,222,804
2026-03-31 $4,966,911 1,103,758
2025-12-31 $137,157 22,302
2025-09-30 $344,848 47,697
2025-06-30 $361,217 68,026
2024-09-30 $3,130,841 114,306
2024-03-31 $715,435 33,557
2022-12-31 $2,133,027 147,004
2022-03-31 $2,293,830 91,025
2020-09-30 $1,022,870 78,441
2020-06-30 $2,581,573 227,652